MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor

[1]  Yifeng Zhou,et al.  Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma. , 2015, Gene.

[2]  Wei Yang,et al.  MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1 , 2015, Oncotarget.

[3]  Grégoire Pau,et al.  Differential effects of targeting Notch receptors in a mouse model of liver cancer , 2015, Hepatology.

[4]  Liang Zhou,et al.  Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. , 2015, International journal of clinical and experimental pathology.

[5]  Sen Lu,et al.  Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1. , 2015, International journal of clinical and experimental pathology.

[6]  S. Zhang,et al.  Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma. , 2015, International journal of clinical and experimental pathology.

[7]  Gang Wang,et al.  MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). , 2015, International journal of clinical and experimental pathology.

[8]  Xifeng Wu,et al.  Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. , 2015, Carcinogenesis.

[9]  Lian-Yue Yang,et al.  MicroRNA‐331‐3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine‐rich repeat protein phosphatase , 2014, Hepatology.

[10]  P. Hersey,et al.  Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma , 2014, BMC Cancer.

[11]  Jie Zhao,et al.  Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation , 2014, Oncotarget.

[12]  C. Decaestecker,et al.  Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer , 2014, Oncology reports.

[13]  Haitao Huang,et al.  miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10. , 2014, International journal of clinical and experimental pathology.

[14]  Quanbo Zhou,et al.  Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell , 2014, Journal of Translational Medicine.

[15]  Deric M. Park,et al.  MicroRNA-608 and MicroRNA-34a Regulate Chordoma Malignancy by Targeting EGFR, Bcl-xL and MET , 2014, PloS one.

[16]  B. Li,et al.  Increased Expression of Macrophage Migration Inhibitory Factor and DJ-1 contribute to Cell Invasion and Metastasis of Nasopharyngeal Carcinoma , 2014, International journal of medical sciences.

[17]  F. Tas,et al.  Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients , 2014, Tumor Biology.

[18]  C. Norbury,et al.  The Long and Short of MicroRNA , 2013, Cell.

[19]  S. Giordano,et al.  MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? , 2013, Hepatology.

[20]  C. Croce,et al.  miRNA profiling of cancer. , 2013, Current opinion in genetics & development.

[21]  L. Leng,et al.  Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.

[22]  J. Błasiak,et al.  The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. , 2012, Acta biochimica Polonica.

[23]  R. Garzon,et al.  Potential of microRNAs for cancer diagnostics, prognostication and therapy , 2012, Current Opinion in Oncology.

[24]  D. Calvisi,et al.  AKT (v‐akt murine thymoma viral oncogene homolog 1) and N‐Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c‐Myc pathways , 2012, Hepatology.

[25]  R. Henrique,et al.  The Epigenetics of Renal Cell Tumors: from Biology to Biomarkers , 2012, Front. Gene..

[26]  O. Slabý,et al.  MicroRNAs and their target gene networks in renal cell carcinoma. , 2011, Biochemical and biophysical research communications.

[27]  W. Cho.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. , 2010, The international journal of biochemistry & cell biology.

[28]  Thijs J. Hagenbeek,et al.  Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.

[29]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[30]  Wen Li,et al.  [Correlations of expressions of macrophage migration inhibitor factor and cyclin D1 with tumor size and metastasis of hepatocellular carcinoma]. , 2007, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[31]  Y. Hishikawa,et al.  Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma , 2005, Cancer.

[32]  Michael Bacher,et al.  Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma , 2003, International journal of cancer.